
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of ProShares UltraShort Nasdaq Biotechnology (NASDAQ:BIS) through any online brokerage.
There are no as such competitors for ProShares UltraShort Nasdaq Biotechnology.
There is no analysis for ProShares UltraShort Nasdaq Biotechnology to provide a consensus price target.
The stock price for ProShares UltraShort Nasdaq Biotechnology (NASDAQ: BIS) is $9.65 last updated December 12, 2025 at 7:01 AM EST.
There are no upcoming dividends for ProShares UltraShort Nasdaq Biotechnology.
ProShares UltraShort Nasdaq Biotechnology does not have any upcoming earnings scheduled.
There is no upcoming split for ProShares UltraShort Nasdaq Biotechnology.
| Sector | Unknown |
| Category | - |
| Investment Style | Trading-Inverse Equity |
| Fund Inception | Apr 6, 2010 |
| Managers | Tarak Dave Michael Neches |
| Definition | - |
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.